Rigel Pharmaceuticals, Inc. (RIGL)
34.57
+0.16
(+0.46%)
USD |
NASDAQ |
Feb 10, 16:00
34.57
0.00 (0.00%)
After-Hours: 17:29
Rigel Pharmaceuticals Total Liabilities (Quarterly) : 124.92M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Nektar Therapeutics | 216.26M |
| Ironwood Pharmaceuticals, Inc. | 660.22M |
| BioMarin Pharmaceutical, Inc. | 1.558B |
| Catalyst Pharmaceuticals, Inc. | 131.36M |
| Amicus Therapeutics, Inc. | 638.39M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 242.53M |
| Shareholders Equity (Quarterly) | 117.61M |
| Debt to Equity Ratio | 0.5176 |
| Current Ratio | 2.277 |
| Net Debt Paydown Yield | -0.02% |